2nd International Congress on Epigenetics & Chromatin

We invite all the participants and attendees from all over the world to attend The 2nd International Conference on Epigenetics and Chromatin 2017 during November 06-08, 2017 which is the only bench to bedside review of the drug discovery and development process.

It will help scientific leaders from academia, pharma and biotech drive advances in novel epigenetic based therapeutics through the latest updates in pre-clinical and clinical translational research from oncology to new exciting disease areas.

This meeting is in Collaboration with The International Society for Cancer Epigenetics Research

Zymo Research Corp. and Diagenode is Exhibiting at this event.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (CME and CPD Credits)

Join us in Frankfurt, Germany to delve deeper into mechanistic understanding, lead compound discovery and development, and methods for forging and promoting collaboration to achieve the translational progression of the next wave of epigenetic therapeutics.

Epigenetics Conference is a novel discussion to unite overall recognized scholastics in the field of Genetics, Genomics and Proteomics Researchers, Public wellbeing experts, Scientists, Academic researchers, Industry specialists, Scholars to trade about condition of the Research and Development.

Point of this gathering is to fortify new views for treatment that will be valuable over the range of Epigenetics. A Unique Opportunity for Advertisers and Sponsors at this International occasion.